Skip to main content
European Commission logo print header

A Collective Research Impact Framework and multi-variate models to foster the true engagement of actors and stakeholders in Health Research and Innovation

Description du projet

Encourager l’engagement des parties prenantes dans les soins de santé

La pandémie de COVID-19 et les coûts de santé croissants associés aux changements démographiques et climatiques figurent parmi les défis auxquels sont confrontés les systèmes de recherche et de soins de santé. La création d’un écosystème de recherche et de soins connecté et responsable, capable de libérer le potentiel de transformation de la science et de la technologie afin de traduire les résultats de la recherche en résultats bénéfiques pour la société, est primordiale. Malheureusement, malgré l’intérêt des parties prenantes pour des modèles de prise de décision plus participatifs, le manque d’approches innovantes de gouvernance et de méthodes d’évaluation de l’impact compromet le retour sur investissement d’un engagement significatif dans la recherche et l’innovation en matière de santé. Le projet MULTI-ACT, financé par l’UE, a développé un modèle innovant d’évaluation collective de l’impact de la recherche, établissant un ensemble multidimensionnel d’indicateurs et de lignes directrices afin d’institutionnaliser l’engagement des parties prenantes.

Objectif

Conventional accountability metrics to measure the impact of health R&I process normally are not able to represent the claims of different actors. The development of a new integrated collective research impact framework will be instrumental in enabling Return Of Investment (ROI) by each involved stakeholder in a view of collective sustainability. Economic and financial dimension (efficiency) has to be integrated with measures of mission success (efficacy), while being accountable to all the stakeholders who are directly or indirectly affected by an organization activity. Starting from the Integrated Accountability Model (IAM) in its different dimensions (mission, economic and social), new and appropriate metrics to evaluate impact of health research will be developed in a multistakeholder participatory approach. The IAM model will be expanded and fine-tuned in a new Collective Research Impact Framework (CRIF) to be applied to Multi-Stakeholder Research Initiatives in the domain of BRAIN diseases. The CRIF will be based on key requirements that will be jointly developed by different actors (i.e. research organizations, industry, civil society organizations, patients organizations, policy makers, governmental institutions): 1)the science of patient input; 2)common classification system to uniformly identify types of health R&I; 3)new metrics to measure the impact of R&I on patients and society; 4)strategic research global agenda and funding models; 5)committed partnership among health R&I stakeholders to create and oversee cooperative ventures; 6)mechanism to determine the nature of health R&I funding on a national level. MULTI-ACT proposal is led by patient organizations that act as mediators between science and patients/society. Addressed Responsible Research and Innovation issues are: Public engagement, Research governance and Research impact assessment as responsible research is the one that produces an impact on people and society.

Appel à propositions

H2020-SwafS-2016-17

Voir d’autres projets de cet appel

Sous appel

H2020-SwafS-2017-1

Coordinateur

FONDAZIONE ITALIANA SCLEROSI MULTIPLA - FISM ETS
Contribution nette de l'UE
€ 577 461,24
Adresse
VIA OPERAI 40
16149 Genova
Italie

Voir sur la carte

Région
Nord-Ovest Liguria Genova
Type d’activité
Research Organisations
Liens
Coût total
€ 577 461,24

Participants (11)